ProfileGDS4516 / 233011_at
TitleColorectal cancer: laser microdissected tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 1 stage: 2a stage: 2b stage: 3a stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM537341 GSM537345 GSM537355 GSM537366 GSM537370 GSM537380 GSM537392 GSM537415 GSM537417 GSM537422 GSM537423 GSM537427 GSM537430 GSM537336 GSM537337 GSM537348 GSM537349 GSM537356 GSM537361 GSM537374 GSM537377 GSM537378 GSM537379 GSM537383 GSM537388 GSM537395 GSM537400 GSM537404 GSM537409 GSM537418 GSM537425 GSM537333 GSM537342 GSM537347 GSM537350 GSM537362 GSM537363 GSM537368 GSM537376 GSM537381 GSM537386 GSM537398 GSM537402 GSM537405 GSM537371 GSM537421 GSM537424 GSM537432 GSM537331 GSM537332 GSM537334 GSM537338 GSM537353 GSM537357 GSM537358 GSM537375 GSM537389 GSM537390 GSM537393 GSM537399 GSM537407 GSM537408 GSM537428 GSM537354 GSM537410 GSM537413 GSM537396 GSM537397 GSM537330 GSM537369 GSM537373 GSM537401 GSM537343 GSM537367 GSM537382 GSM537385 GSM537391 GSM537419 GSM537420 GSM537429 GSM537431 GSM537387 GSM537414 GSM537433 GSM537335 GSM537339 GSM537340 GSM537344 GSM537346 GSM537351 GSM537352 GSM537359 GSM537360 GSM537364 GSM537365 GSM537372 GSM537384 GSM537394 GSM537403 GSM537406 GSM537411 GSM537412 GSM537416 GSM537426 39% 41% 23% 39% 40% 40% 20% 51% 20% 69% 8% 26% 7% 67% 33% 25% 13% 27% 61% 25% 31% 23% 16% 10% 13% 18% 62% 15% 12% 30% 67% 67% 20% 18% 29% 20% 15% 47% 14% 55% 43% 49% 18% 27% 24% 12% 55% 60% 30% 29% 30% 23% 19% 80% 10% 31% 30% 16% 40% 17% 22% 15% 19% 42% 16% 19% 19% 21% 16% 52% 42% 41% 18% 38% 14% 16% 7% 14% 30% 41% 29% 22% 32% 15% 15% 39% 18% 17% 13% 87% 10% 22% 27% 77% 32% 54% 72% 14% 19% 36% 17% 23% 21% 13% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM537341patient 115, cancer, LCM [OPG study]4.7746939
GSM537345patient 119, cancer, LCM [OPG study]4.8652141
GSM537355patient 138, cancer, LCM [OPG study]4.0279223
GSM537366patient 154, cancer, LCM [OPG study]4.7818239
GSM537370patient 022, cancer, LCM [OPG study]4.7609340
GSM537380patient 037, cancer, LCM [OPG study]4.80340
GSM537392patient 077, cancer, LCM [OPG study]3.8592920
GSM537415patient 032, cancer, LCM [OPG study]5.4174451
GSM537417patient 042, cancer, LCM [OPG study]3.9679820
GSM537422patient 059, cancer, LCM [OPG study]6.7511369
GSM537423patient 064, cancer, LCM [OPG study]3.387428
GSM537427patient 084, cancer, LCM [OPG study]4.1057826
GSM537430patient 090, cancer, LCM [OPG study]3.364997
GSM537336patient 107, cancer, LCM [OPG study]6.6166667
GSM537337patient 108, cancer, LCM [OPG study]4.4211133
GSM537348patient 124, cancer, LCM [OPG study]4.0905225
GSM537349patient 125, cancer, LCM [OPG study]3.6210613
GSM537356patient 139, cancer, LCM [OPG study]4.1897227
GSM537361patient 147, cancer, LCM [OPG study]6.1441361
GSM537374patient 026, cancer, LCM [OPG study]4.1314525
GSM537377patient 033, cancer, LCM [OPG study]4.4077131
GSM537378patient 034, cancer, LCM [OPG study]3.9885323
GSM537379patient 036, cancer, LCM [OPG study]3.7586416
GSM537383patient 046, cancer, LCM [OPG study]3.4929510
GSM537388patient 063, cancer, LCM [OPG study]3.6041913
GSM537395patient 082, cancer, LCM [OPG study]3.764218
GSM537400patient 099, cancer, LCM [OPG study]6.2399962
GSM537404patient 129, cancer, LCM [OPG study]3.7616415
GSM537409patient 141, cancer, LCM [OPG study]3.545212
GSM537418patient 044, cancer, LCM [OPG study]4.2745330
GSM537425patient 070, cancer, LCM [OPG study]6.6075967
GSM537333patient 102, cancer, LCM [OPG study]6.6349667
GSM537342patient 116, cancer, LCM [OPG study]3.8933920
GSM537347patient 123, cancer, LCM [OPG study]3.8555918
GSM537350patient 127, cancer, LCM [OPG study]4.2967429
GSM537362patient 148, cancer, LCM [OPG study]3.922820
GSM537363patient 150, cancer, LCM [OPG study]3.7129915
GSM537368patient 156, cancer, LCM [OPG study]5.2600747
GSM537376patient 031, cancer, LCM [OPG study]3.6693714
GSM537381patient 038, cancer, LCM [OPG study]5.7830955
GSM537386patient 057, cancer, LCM [OPG study]5.0421643
GSM537398patient 094, cancer, LCM [OPG study]5.3700249
GSM537402patient 109, cancer, LCM [OPG study]3.8275418
GSM537405patient 130, cancer, LCM [OPG study]4.2645227
GSM537371patient 023, cancer, LCM [OPG study]4.0643624
GSM537421patient 055, cancer, LCM [OPG study]3.5571712
GSM537424patient 065, cancer, LCM [OPG study]5.7566655
GSM537432patient 097, cancer, LCM [OPG study]6.0941360
GSM537331patient 100, cancer, LCM [OPG study]4.3344930
GSM537332patient 101, cancer, LCM [OPG study]4.248329
GSM537334patient 103, cancer, LCM [OPG study]4.3595230
GSM537338patient 110, cancer, LCM [OPG study]4.0271223
GSM537353patient 135, cancer, LCM [OPG study]3.835119
GSM537357patient 142, cancer, LCM [OPG study]8.0342280
GSM537358patient 143, cancer, LCM [OPG study]3.4749610
GSM537375patient 030, cancer, LCM [OPG study]4.4016931
GSM537389patient 068, cancer, LCM [OPG study]4.2630130
GSM537390patient 072, cancer, LCM [OPG study]3.7120516
GSM537393patient 078, cancer, LCM [OPG study]4.7974840
GSM537399patient 095, cancer, LCM [OPG study]3.7730717
GSM537407patient 133, cancer, LCM [OPG study]4.0359222
GSM537408patient 140, cancer, LCM [OPG study]3.7198615
GSM537428patient 086, cancer, LCM [OPG study]3.8553119
GSM537354patient 136, cancer, LCM [OPG study]4.9135542
GSM537410patient 146, cancer, LCM [OPG study]3.7319316
GSM537413patient 027, cancer, LCM [OPG study]3.7918719
GSM537396patient 083, cancer, LCM [OPG study]3.8570619
GSM537397patient 088, cancer, LCM [OPG study]3.8988621
GSM537330patient 006, cancer, LCM [OPG study]3.7650416
GSM537369patient 015, cancer, LCM [OPG study]5.5502652
GSM537373patient 025, cancer, LCM [OPG study]4.944442
GSM537401patient 106, cancer, LCM [OPG study]4.9338741
GSM537343patient 117, cancer, LCM [OPG study]3.7943618
GSM537367patient 155, cancer, LCM [OPG study]4.7848438
GSM537382patient 041, cancer, LCM [OPG study]3.6675414
GSM537385patient 053, cancer, LCM [OPG study]3.7287416
GSM537391patient 073, cancer, LCM [OPG study]3.340487
GSM537419patient 045, cancer, LCM [OPG study]3.6852114
GSM537420patient 052, cancer, LCM [OPG study]4.388230
GSM537429patient 089, cancer, LCM [OPG study]4.830441
GSM537431patient 096, cancer, LCM [OPG study]4.3967929
GSM537387patient 061, cancer, LCM [OPG study]3.9477322
GSM537414patient 028, cancer, LCM [OPG study]4.4023632
GSM537433patient 098, cancer, LCM [OPG study]3.7162615
GSM537335patient 104, cancer, LCM [OPG study]3.6675215
GSM537339patient 111, cancer, LCM [OPG study]4.7120939
GSM537340patient 113, cancer, LCM [OPG study]3.822218
GSM537344patient 118, cancer, LCM [OPG study]3.771717
GSM537346patient 011, cancer, LCM [OPG study]3.6315513
GSM537351patient 128, cancer, LCM [OPG study]8.8589187
GSM537352patient 134, cancer, LCM [OPG study]3.4772810
GSM537359patient 144, cancer, LCM [OPG study]4.0121522
GSM537360patient 145, cancer, LCM [OPG study]4.1660127
GSM537364patient 152, cancer, LCM [OPG study]7.5305377
GSM537365patient 153, cancer, LCM [OPG study]4.4547532
GSM537372patient 024, cancer, LCM [OPG study]5.6842954
GSM537384patient 048, cancer, LCM [OPG study]7.0151372
GSM537394patient 081, cancer, LCM [OPG study]3.6703814
GSM537403patient 121, cancer, LCM [OPG study]3.8645119
GSM537406patient 131, cancer, LCM [OPG study]4.641836
GSM537411patient 149, cancer, LCM [OPG study]3.8644417
GSM537412patient 019, cancer, LCM [OPG study]4.0808723
GSM537416patient 035, cancer, LCM [OPG study]3.891321
GSM537426patient 079, cancer, LCM [OPG study]3.5452413